IPO lockup expiration: what investors should expect

A simple definition

An IPO lockup period is a contractual restriction that prevents company insiders and pre-IPO shareholders from selling their shares for a set time after the company goes public. While the lockup is in force, the only shares trading are the ones sold in the offering itself. Everyone else — employees with vested equity, founders, venture investors — holds and waits.

The lockup is not a law. It is an agreement, typically between shareholders and the underwriters managing the IPO, and its terms are spelled out in the offering documents.

Why lockups exist

Lockups exist to keep the supply of shares manageable while the market finds its footing on a newly public stock. A typical IPO floats a minority of the company's total shares. If every pre-IPO holder could sell on day one, the supply hitting the market could overwhelm early demand and undermine the offering price the underwriters worked to set.

There's a signaling function too. A founder dumping shares in week two of trading tells the market something, whether or not it's true. Lockups take that question off the table for a while, giving public investors a window to evaluate the business on its results rather than on insider behavior.

Typical timelines

Most IPO lockups run 90 to 180 days from the offering, with 180 days the most common term in traditional IPOs. Some companies structure staggered lockups that release shares in tranches — a portion after the first earnings report, more at later dates — rather than all at once.

Recent years have added variations. Some IPOs include early-release provisions that unlock a portion of shares ahead of schedule if the stock trades above a set price threshold. Direct listings often skip the lockup entirely. The 180-day single-date lockup is still the default, but it is no longer the only pattern, which is one reason checking the specific terms matters.

How expiration dates are determined

Lockup terms are set in the agreements signed during the IPO process and disclosed in the company's prospectus, filed with the SEC as part of the S-1 registration. The filing spells out the duration, which holders are covered, and any early-release or staggered provisions. Underwriters also generally retain the right to waive the lockup early, though waivers for large holders are uncommon and tend to be disclosed.

For any specific company, the expiration date is public information. The prospectus is the primary source; financial data providers also track upcoming expirations.

Increased share supply

The mechanical effect is simple: the pool of shares eligible to trade gets bigger, sometimes several times bigger. In many IPOs, the shares released at lockup expiration outnumber the shares sold in the offering itself. When Facebook went public in 2012, its lockups expired in stages over the following year, and the largest single release made more shares eligible for sale than the IPO had offered.

Eligible is the operative word. Expiration permits selling; it doesn't compel it. How much of the newly eligible supply actually reaches the market depends on the decisions of thousands of individual holders, each with their own cost basis, tax situation, and view of the company.

Potential impact on stock price

Markets anticipate lockup expirations, since the dates are disclosed months in advance. Even so, expiration can bring elevated trading volume and price volatility as new supply meets existing demand. Academic research on lockup expirations, including a cited study by Laura Field and Gordon Hanka published in the Journal of Finance in 2001, has found small negative average returns around expiration dates and a lasting increase in trading volume afterward — though averages conceal wide variation from one stock to the next.

Some stocks decline into and through expiration. Others barely react, because the selling was already priced in. A few rise, sometimes sharply, when feared insider selling fails to materialize. Facebook's largest 2012 unlock was one of the surprises: the stock rose double digits that day. Past patterns describe what has happened, not what will happen in any particular case.

Evaluate sell vs. hold strategy

For insiders and pre-IPO shareholders, expiration converts a paper position into a real decision. The considerations are individual: concentration (how much of your net worth sits in one stock), tax treatment (holding periods, exercise timing for options, applicable qualified small business stock rules), liquidity needs, and your view of the company's prospects at the current price.

There is no universally correct answer, which is precisely why a plan made before the expiration date tends to serve better than a reaction made during it. Many holders consider selling in stages rather than all at once. Shareholders weighing these decisions should consult their own tax and financial advisors — the variables differ enough from person to person that general guidance only goes so far.

Monitor market conditions

The same unlock can land very differently depending on what the market looks like when it arrives. Demand for the stock, the company's recent results, sector sentiment, and overall market conditions all shape how new supply is absorbed. An expiration that follows a strong earnings report meets a different market than one that follows a guidance cut.

Holders can't control the calendar, but they can watch it. Knowing where the expiration date falls relative to earnings announcements and other disclosure events helps frame what the trading environment might look like — without predicting it.

Price drops due to selling pressure

The most discussed risk is the obvious one: concentrated selling by insiders can push the price down, at least temporarily. Large blocks from a founder or an early fund can weigh on a stock with limited float, and the anticipation of selling can move the price before a single unlocked share trades. For public investors who bought after the IPO, expiration is a supply event they didn't create but still absorb.

The risk is real but not uniform. Stocks with small floats, big insider stakes, and rich valuations have historically been more exposed to expiration-related pressure than those where most shares already trade freely.

Timing risk for exits

For the insiders themselves, the risk runs in both directions. Sell at the first opportunity and you may be exiting into the worst supply-demand imbalance the stock will ever face. Wait, and you carry concentrated single-stock exposure through whatever comes next — earnings misses, market drawdowns, sector rotations. Either choice can look wrong in hindsight.

This is timing risk, and it cannot be eliminated, only managed. Staged selling, pre-set price levels, and 10b5-1 trading plans (which schedule sales in advance under SEC rules) are among the tools holders use to take emotion and headline-watching out of the decision. None guarantees a good outcome; each trades some upside for some discipline.

The lockup problem starts before the IPO. Shareholders in late-stage private companies often hold the bulk of their net worth in stock they cannot sell, with an IPO date they don't control and a lockup period after that. The waiting can stretch years past the point where a holder would have chosen to diversify.

Pre-IPO secondary markets address part of that gap. Augment operates a private marketplace where shareholders in private companies can pursue subject to company approval, transfer restrictions, and eligibility requirements. For accredited investors on the buy side, Augment's pre-IPO investment platform pools capital into vehicles targeting private companies.

For buyers, understanding the lockup calendar matters in the other direction: shares purchased pre-IPO are generally subject to the same lockup as insider shares once the company goes public. Augment's platform is built to make the terms, restrictions, and process around these transactions clear before anyone commits — informed decisions start with knowing exactly what you hold and when you can sell it.

A lockup is a delay, not a destination. It postpones insider liquidity so a new stock can find its market, and when it expires, the supply picture changes — sometimes dramatically, sometimes not at all. The date is public, the mechanics are knowable, and the research says outcomes vary too much for anyone to treat expiration as a predictable trade.

What holders can control is preparation. Knowing the terms, understanding the tax picture, and deciding on an approach before the date arrives all reduce the odds of making a concentrated, emotional decision in a volatile week. And increasingly, the planning starts earlier than the IPO itself — in the private markets, where secondary transactions let shareholders manage concentration years before a lockup is ever signed. That earlier market is the one Augment is building.